FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Owen Dempsey

Research Profile

Procedures

Disorders

Chemicals & Drugs

Devices

Nebulizers and Vaporizers

Concepts & Ideas

Co-author Network

Publications

TOP 3
Graeme P Currie; Daniel K C Lee; Owen J Dempsey; Stephen J Fowler; Louise M Cowan; Brian J Lipworth
A proof of concept study to evaluate putative benefits of montelukast in moderate persistent asthmatics.
Owen J Dempsey; Stephen J Fowler; Andrew Wilson; Gwen Kennedy; Brian J Lipworth
Effects of adding either a leukotriene receptor antagonist or low-dose theophylline to a low or medium dose of inhaled corticosteroid in patients with persistent asthma.
Owen J Dempsey; Gwen Kennedy; Brian J Lipworth
Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Owen Dempsey (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Graeme P Currie; Daniel K C Lee; Owen J Dempsey; Stephen J Fowler; Louise M Cowan; Brian J Lipworth
A proof of concept study to evaluate putative benefits of montelukast in moderate persistent asthmatics.
British journal of clinical pharmacology 2003;55(6):609-15.
2002: Owen J Dempsey; Stephen J Fowler; Andrew Wilson; Gwen Kennedy; Brian J Lipworth
Effects of adding either a leukotriene receptor antagonist or low-dose theophylline to a low or medium dose of inhaled corticosteroid in patients with persistent asthma.
Chest 2002;122(1):151-9.
2002: Owen J Dempsey; Gwen Kennedy; Brian J Lipworth
Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma.
The Journal of allergy and clinical immunology 2002;109(1):68-74.
2001: Owen J Dempsey; M Humphreys; Wendy J R Coutie; Brian J Lipworth
Relative lung delivery of fluticasone propionate via large volume spacer or nebuliser in healthy volunteers.
European journal of clinical pharmacology 2001;57(9):637-41.
2001: Andrew M Wilson; Owen J Dempsey; Erika J Sims; Brian J Lipworth
A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2001;31(4):616-24.
2001: Andrew M Wilson; Owen J Dempsey; Erika J Sims; Brian J Lipworth
Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
Chest 2001;119(4):1021-6.
2000: Owen J Dempsey
Leukotriene receptor antagonist therapy.
Postgraduate medical journal 2000;76(902):767-73.
2000: Stephen J Fowler; Owen J Dempsey; Erika J Sims; Brian J Lipworth
Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Relationship to asthma severity and beta(2)-receptor genotype.
American journal of respiratory and critical care medicine 2000;162(4 Pt 1):1318-22.
2000: Andrew M Wilson; Linda C Orr; Erika J Sims; Owen J Dempsey; Brian J Lipworth
Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma.
American journal of respiratory and critical care medicine 2000;162(4 Pt 1):1297-301.
2000: Andrew M Wilson; Owen J Dempsey; Erika J Sims; Brian J Lipworth
Subjective and objective markers of treatment response in patients with seasonal allergic rhinitis.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2000;85(2):111-4.
2000: Brian J Lipworth; Owen J Dempsey; I Aziz; Andrew M Wilson
Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype.
The American journal of medicine 2000;109(2):114-21.
2000: Brian J Lipworth; Owen J Dempsey; I Aziz
Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
Chest 2000;118(2):321-8.
2000: A Wilson; Owen J Dempsey; Erika J Sims; Wendy J R Coutie; M C Paterson; Brian J Lipworth
Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2000;30(6):833-8.
2000: Owen J Dempsey; Andrew M Wilson; Erika J Sims; C Mistry; Brian J Lipworth
Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids.
Chest 2000;117(4):950-3.
1999: Owen J Dempsey; Andrew M Wilson; Wendy J R Coutie; Brian J Lipworth
Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler.
Chest 1999;116(4):935-40.
1999: Owen J Dempsey; Wendy J R Coutie; Andrew M Wilson; P Williams; Brian J Lipworth
Evaluation of the buccal component of systemic absorption with inhaled fluticasone propionate.
Thorax 1999;54(7):614-7.
1999: Owen J Dempsey; A M Wilson; Brian J Lipworth
Spacer devices increase dose of inhaled corticosteroids delivered.
BMJ (Clinical research ed.) 1999;318(7200):1764.
1999: Andrew M Wilson; Owen J Dempsey; Wendy J R Coutie; Erika J Sims; Brian J Lipworth
Importance of drug-device interaction in determining systemic effects of inhaled corticosteroids.
Lancet 1999;353(9170):2128.